Reimbursement

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The National Comprehensive Cancer Network seeks to address issues related to treating HIV-positive patients with cancer, such as the potential for drug interactions.

The standardization of value-based models is crucial as they become widely-adopted.

A recent report highlights how Americans pay more for prescription drugs compared with other countries.

Less serious adverse events remain a concern for patients treated for chronic diseases.

Top news of the day from across the health care landscape.

Tisagenlecleucel (Kymriah) induced remission in a patient with acute lymphoblastic leukemia who was seemingly out of options.

Approximately 78% of survey respondents said that direct and indirect remuneration fees reduce the predictability of cash flow.

Top news of the day from across the health care landscape.

Pre-exposure prophylaxis is highly effective preventing HIV if used as prescribed.

Pharmacists rank fifth among the most honest and ethical professionals in the United States, according to the latest Gallup poll.

The risk of non-Hodgkin's lymphoma is elevated in patients with hepatitis C virus.

Chronic HCV infection has been linked to low serum zinc and low metallothioneins expression in liver cells.

Technology-driven customer intelligence and analytics allow specialty pharmacies to connect with patients before they drift from proper habits.

Identifying current deficiencies in clinical practice can help pinpoint care practices that can be implemented for cancer survivors.

Many factors influence whether a specialty pharmacy can gain access to limited distribution drug networks.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Patients with both hepatitis C and type 2 diabetes can develop fibrosis, steatosis, hepatocellular carcinoma, and resistance to antiviral treatment.

Participants in the Transform Rheumatoid Arthritis Care program could save 5% on drug spend.

A majority of patients with hepatitis C experience disorders outside of the liver that are related to the virus.

A combination VEGFR-2 inhibitor plus an anti–PD-L1 agent demonstrated antitumor activity in patients with previously treated advanced gastric or gastroesophageal junction adenocarcinoma.

Cabometyx found to improve median overall survival by 2.2 months in patients with previously treated advanced hepatocellular carcinoma.

The federal government previously ruled that dual eligibles would need to use the Medicare part D program for prescriptions preferentially.